Virbac first-half 2026 revenue rises to €768 million, confirms upper-end guidance

Animal health group reported 7.4% growth at constant exchange rate and scope, with North America posting double-digit growth and adjusted recurring operating income margin guidance kept at around 17%.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.